The Effect of Corticosteroid Withdrawal on Glucose Metabolism and Anti-GAD Antibodies in Simultaneous Pancreas–Kidney Transplant Patients
暂无分享,去创建一个
Rogério Silicani Ribeiro | E. Esmatjes | A. Amor | J. Ferrer | M. Ricart | M. Cristelli | Vanessa Guerrero
[1] H. Seers,et al. OUTCOME , 1977, How to Win Your Case.
[2] R. Redfield,et al. Simultaneous pancreas and kidney transplantation: current trends and future directions , 2015, Current opinion in organ transplantation.
[3] A. Israni,et al. OPTN/SRTR 2013 Annual Data Report: Pancreas , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] A. Webster,et al. Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients. , 2014, The Cochrane database of systematic reviews.
[5] Anabela S Rodrigues,et al. Pancreatic autoantibodies after pancreas–kidney transplantation – do they matter? , 2014, Clinical transplantation.
[6] L. Mandarino,et al. Calcineurin inhibition and new-onset diabetes mellitus after transplantation. , 2013, Transplantation.
[7] H. Reijonen,et al. Recurrence of autoimmunity in pancreas transplant patients: research update. , 2011, Diabetes management.
[8] Amanda Jiménez,et al. Pancreas and kidney transplantation: long‐term endocrine function , 2010, Clinical transplantation.
[9] S. Knight,et al. Steroid Avoidance or Withdrawal After Renal Transplantation Increases the Risk of Acute Rejection but Decreases Cardiovascular Risk. A Meta-Analysis , 2010, Transplantation.
[10] A. Cabrita,et al. Pancreas-kidney transplantation and the evolution of pancreatic autoantibodies. , 2009, Transplantation proceedings.
[11] R. Pelletier,et al. Steroid-Free Maintenance Immunosuppression With Rapamune and Low-Dose Neoral in Pancreas Transplant Recipients , 2007, Transplantation.
[12] R. Landgraf,et al. Insulin and islet autoantibodies after pancreas transplantation , 2005, Transplant international : official journal of the European Society for Organ Transplantation.
[13] R. Kandaswamy,et al. Calcineurin Inhibitor- and Steroid-Free Immunosuppression in Pancreas-Kidney and Solitary Pancreas Transplantation , 2005, Transplantation.
[14] A. Secchi,et al. Metabolic results 3 years after simultaneous pancreas-kidney transplantation. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[15] T. Egeland,et al. Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. , 2004, Journal of the American Society of Nephrology : JASN.
[16] P. Stock,et al. Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation. , 2003, Archives of surgery.
[17] M. Abecassis,et al. A PROSPECTIVE STUDY OF RAPID CORTICOSTEROID ELIMINATION IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION: Comparison of Two Maintenance Immunosuppression Protocols: Tacrolimus/Mycophenolate Mofetil Versus Tacrolimus/Sirolimus1 , 2002, Transplantation.
[18] B. Wolffenbuttel,et al. Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression. , 2002, Journal of the American Society of Nephrology : JASN.
[19] F. Citterio. Steroid side effects and their impact on transplantation outcome. , 2001, Transplantation.
[20] B. Wolffenbuttel,et al. Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study. , 2001, Journal of the American Society of Nephrology : JASN.
[21] C. Thivolet,et al. Combined analysis of autoantibodies against beta-cells for prediction of pancreas allograft failure. , 2000, Transplantation proceedings.
[22] B. Hocher,et al. Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] F. Andreelli,et al. Evidence of recurrent type I diabetes following HLA-mismatched pancreas transplantation. , 2000, Diabetes & metabolism.
[24] J. Fung,et al. Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. , 2000, Transplantation.
[25] R. Casamitjana,et al. Recurrence of immunological markers for type 1 (insulin-dependent) diabetes mellitus in immunosuppressed patients after pancreas transplantation. , 1998, Transplantation.
[26] F. Reinholt,et al. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. , 1996, The New England journal of medicine.
[27] R. Nakhleh,et al. Characterization of T Lymphocytes Infiltrating Human Pancreas Allograft Affected by Isletitis and Recurrent Diabetes , 1992, Diabetes.
[28] D. Sutherland,et al. Recurrence of Disease in Pancreas Transplants , 1989, Diabetes.